Three new dual degrees open pathways between Australia and Indonesia

Singapore, Sept. 3 -- Students will have new opportunities to study across Melbourne and Indonesia with three dual degree programmes launched by the University of Melbourne and Universitas Gadjah Mada... Read More

China's Biocytogen teams up with Qilu Pharma to support drug development in neuroscience

Singapore, Sept. 3 -- Biocytogen Pharmaceuticals (Beijing) has entered into a non-exclusive licensing agreement with Qilu Pharmaceutical for a fully human VHH antibody molecule. Under the agreement, B... Read More

US FDA approves Taiwan-based PharmaEssentia's BESREMi(R) to treat rare blood disorder

Singapore, Sept. 3 -- PharmaEssentia USA Corporation, a subsidiary of Taiwan-based PharmaEssentia Corporation, has announced that the US Food and Drug Administration (FDA) has approved BESREMi(R) (rop... Read More

Thailand LAB INTERNATIONAL 2026 Opens in Bangkok, Putting Asia's Lab and Life Sciences Innovation in Focus

Singapore, Sept. 2 -- Thailand LAB INTERNATIONAL 2026 kicks off today at the Bangkok International Trade & Exhibition Centre (BITEC), bringing together the laboratory, biotechnology, chemicals and lif... Read More

Most Assets Die on Fit, Not on Data

Singapore, Sept. 2 -- "Almost every company preparing for a partnering conversation prepares for the wrong gate. The rejection usually happens earlier in the process than founders imagine, and for rea... Read More

Bridges Are Not Symmetrical: Reading the Asia Bio Cross-Border Keynote

Singapore, Sept. 2 -- Cross-border partnership is usually discussed as two parties meeting in the middle. The more accurate picture is a structure with one engineered end and one improvised end, and S... Read More

Ascletis doses first participant in global Phase III trial of oral GLP-1 candidate ASC30

Singapore, Sept. 2 -- Ascletis Pharma has dosed the first participant in its global Phase III clinical programme evaluating ASC30, an investigational once-daily oral small molecule GLP-1 receptor agon... Read More

Singapore becomes first ASEAN market to subsidise vutrisiran for transthyretin amyloidosis

Singapore, Sept. 2 -- Singapore has become the first ASEAN country to provide government subsidies for eligible patients receiving vutrisiran for transthyretin amyloidosis. From 1 September 2026, vut... Read More

Singapore expands subsidised access to Roche's Columvi for relapsed or refractory DLBCL

Singapore, Sept. 2 -- Singapore is expanding subsidised access to Roche's Columvi, or glofitamab, for eligible patients with relapsed or refractory diffuse large B-cell lymphoma. From 1 September 202... Read More

DIPG Alliance to raise S$5 M over five years to establish Singapore's first enduring paediatric brain tumour research fund

Singapore, Sept. 2 -- DIPG Alliance, Singapore's first charitable foundation dedicated to advancing research for Diffuse Intrinsic Pontine Glioma (DIPG) and other paediatric brain cancers, has been es... Read More

• 1
• 2
• 3
• 4
• 5
• 6
• 7
• 8
• 9
• 10
• »
• »»